Effects of coffee and tea consumption on glioma risk: An umbrella review of systematic reviews and meta-analyses

IF 2.9 Q3 NUTRITION & DIETETICS Clinical nutrition ESPEN Pub Date : 2024-08-22 DOI:10.1016/j.clnesp.2024.08.013

Hamid Abbasi , Emad Alem , Farnush Bakhshimoghaddam , Sara khoshdooz , Saeid Doaei

{"title":"Effects of coffee and tea consumption on glioma risk: An umbrella review of systematic reviews and meta-analyses","authors":"Hamid Abbasi , Emad Alem , Farnush Bakhshimoghaddam , Sara khoshdooz , Saeid Doaei","doi":"10.1016/j.clnesp.2024.08.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Coffee and tea are considered to have some effects on the risk of glioma as one of the most prevalent intracranial malignant tumors in adults. However, the precise effect of coffee and tea consumption on glioma is not obvious. This umbrella review aimed to evaluate the impact of tea and coffee consumption on glioma risk.</p></div><div><h3>Methods</h3><p>Three online databases containing Scopus, Web of Science, and PubMed were thoroughly searched from the beginning to February 23, 2024 with no language constraints. Relying on I<sup>2</sup> and Q statistics, a random-effect model or a fixed-effect model was applied. The PICO structure was followed as Population (Patients with glioma), Intervention (Coffee and tea consumption), Comparison (Standard treatment or placebo), and Outcome (Risk of glioma).</p></div><div><h3>Results</h3><p>Totally, seven meta-analyses and systematic reviews contain 23,591 patients were included in this umbrella review. Coffee and tea consumption led to significant 15% and 16% reductions in glioma risk, respectively (RR = 0.85; 95% CI: 0.74, 0.98; RR = 0.84; 95% CI: 0.79, 0.89). The results did not change after subgroup analyses.</p></div><div><h3>Conclusion</h3><p>This umbrella review revealed that the coffee and tea consumption may decrease the glioma risk. Consumption of tea and coffee may be considered as dietary strategies against glioma.</p></div><div><h3>PROSPERO registration code</h3><p>CRD42024521525.</p></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 37-43"},"PeriodicalIF":2.9000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457724012853","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Coffee and tea are considered to have some effects on the risk of glioma as one of the most prevalent intracranial malignant tumors in adults. However, the precise effect of coffee and tea consumption on glioma is not obvious. This umbrella review aimed to evaluate the impact of tea and coffee consumption on glioma risk.

Methods

Three online databases containing Scopus, Web of Science, and PubMed were thoroughly searched from the beginning to February 23, 2024 with no language constraints. Relying on I² and Q statistics, a random-effect model or a fixed-effect model was applied. The PICO structure was followed as Population (Patients with glioma), Intervention (Coffee and tea consumption), Comparison (Standard treatment or placebo), and Outcome (Risk of glioma).

Results

Totally, seven meta-analyses and systematic reviews contain 23,591 patients were included in this umbrella review. Coffee and tea consumption led to significant 15% and 16% reductions in glioma risk, respectively (RR = 0.85; 95% CI: 0.74, 0.98; RR = 0.84; 95% CI: 0.79, 0.89). The results did not change after subgroup analyses.

Conclusion

This umbrella review revealed that the coffee and tea consumption may decrease the glioma risk. Consumption of tea and coffee may be considered as dietary strategies against glioma.

PROSPERO registration code

CRD42024521525.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

饮用咖啡和茶对神经胶质瘤风险的影响：系统综述和元分析总览

背景：神经胶质瘤是成人中最常见的颅内恶性肿瘤之一，人们认为咖啡和茶对神经胶质瘤有一定的影响。然而，饮用咖啡和茶对胶质瘤的确切影响并不明显。本综述旨在评估饮用茶和咖啡对胶质瘤风险的影响：方法：对 Scopus、Web of Science 和 PubMed 三个在线数据库进行了全面检索，检索时间从开始到 2024 年 2 月 23 日，没有语言限制。根据 I2 和 Q 统计量，采用随机效应模型或固定效应模型。PICO结构为人群（胶质瘤患者）、干预（饮用咖啡和茶）、比较（标准治疗或安慰剂）和结果（胶质瘤风险）：本综述共纳入了七项荟萃分析和系统综述，包含 23591 名患者。饮用咖啡和茶可使胶质瘤风险分别显著降低15%和16%（RR= 0.85; 95% CI: 0.74, 0.98; RR= 0.84; 95% CI: 0.79, 0.89）。亚组分析后，结果没有变化：本综述显示，饮用咖啡和茶可降低胶质瘤风险。饮用茶和咖啡可被视为预防胶质瘤的饮食策略：CRD42024521525。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical nutrition ESPEN NUTRITION & DIETETICS-

CiteScore

4.90

自引率

3.30%

发文量

512

期刊介绍： Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.